Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy

Annals of Neurology

Volumn 49, Issue 1, 2001, Pages 14-23

  Yamada, Mitsunori ^a   Wood, Jonathan D ^b   Shimohata, Takayoshi ^a   Hayashi, Shintaro ^a   Tsuji, Shoji ^a   Ross, Christopher A ^b   Takahashi, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPHIN 1; CELL PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MUTANT PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CASE REPORT; CELL NUCLEUS INCLUSION BODY; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DENTATORUBROPALLIDOLUYSIAN ATROPHY; EPILEPSY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MYOCLONIC EPILEPSIES, PROGRESSIVE; NERVE TISSUE PROTEINS; NEURONS;

EID: 0035112686     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200101)49:1<14::AID-ANA5>3.0.CO;2-X     Document Type: Article

References (48)

1. Familial myoclonus epilepsy and choreoathetosis: Hereditary dentatorubral-pallidoluysian atrophy
2. When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases
3. Unstable expansion of triplet repeats as a new disease mechanism for neurodegenerative diseases
4. Hereditary dentatorubral-pallidoluysian atrophy: Clinical and pathologic variants in a family
5. Neuropathology of dentatorubro-pallidoluysian atrophy
6. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
7. Spinocerebellar ataxia type 7 (SCA7): A neurodegenerative disorder with neuronal intranuclear inclusions
8. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3
9. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures
10. Hereditary dentatorubral-pallidoluysian atrophy: Detection of widespread ubiquitinated neuronal and glial intranuclear inclusions in the brain
11. Suppression of aggregate formation and apoptosis by transglutaminase inhibitions in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch
12. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
13. Formation of intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
14. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila
15. Polyglutamine pathogenesis
16. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
17. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA
18. Intranuclear neuronal inclusions: A common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?
19. Ubiquitinated filamentous inclusions in the DRPLA cerebellar dentate nucleus neurons contain expanded polyglutamine stretches
20. Widespread expression of the Huntington's disease gene (IT15) protein product
21. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias
22. The N-terminal domain of the human TATA-binding protein plays a role in transcription from TATA-containing RNA polymerase II and III promoters
23. From neuronal inclusions to neurodegeneration: Neuropathological investigation of a transgenic mouse model of Huntington's disease
24. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
25. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
26. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
27. CNS changes in DRPLA with dementia and personality changes: CT, MR and SPECT findings
28. CT findings of hereditary dentatorubral-pallidoluysian atrophy (DRPLA)
29. Atrophy of the cerebellum and brainstem in dentatorubral pallidoluysian atrophy: Influence of CAG repeat size on MRI findings
30. Dentatorubral-pallidoluysian atrophy (DRPLA): Clinical, genetic, and neuroradiologic studies in a family
31. The brainstem region in hereditary dentatorubropallidoluysian atrophy
32. High-intensity proton and T2-weighted MRI signals in the globus pallidus in juvenile-type of dentatorubral and pallidoluysian atrophy
33. Abnormal gene product identified in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) brain
34. Expression and distribution of the dentatorubral-pallidoluysian atrophy gene product (atrophin-1/drplap) in neuronal and nonneuronal tissues
35. Two inter-dependent basic domains in nucleoplasm in nuclear targeting sequence: Identification of a class of bipartite nuclear targeting sequence
36. Intracellular aggregate formation of dentatorubral-pallidoluysian atrophy (DRPLA) protein with the extended polyglutamine
37. Hereditary dentatorubral-pallidoluysian atrophy: Ubiquitinated filamentous inclusions in the cerebellar dentate nucleus neurons
38. Abnormal dentatorubral-pallidoluysian atrophy (DRPLA) protein complex is pathologically ubiquitinated in DRPLA brains
39. Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy
40. Formation of polyglutamine inclusions in non-CNS tissue
41. Structure and function in the nucleus
42. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies
43. PML induces a novel caspase-independent death process
44. PML is essential for multiple apoptotic pathways
45. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body
46. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures
47. Evidence for proteasome involvement in polyglutamine disease: Localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro
48. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells